Sernova (TSE:SVA) has released an update.
Sernova Corp. is conducting a marketed public offering aiming to raise between $6.5 million to $10 million, with shares and warrants priced at $0.33 and $0.40 respectively. The funds are intended for expanding a clinical study, R&D, and general corporate purposes, with notable participation from Evotec SE, its major shareholder. The offering, led by Stifel Nicolaus Canada Inc. and a syndicate of agents, is expected to close by June 20, 2024, subject to regulatory approvals.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
